Sudarshan Chemical Industries Limited has informed the Exchange about Copy of Newspaper Publication
SUDARSCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Chemical Industries has submitted copies of newspaper advertisements (published in Financial Express and Loksatta on 27 July 2025) of its audited standalone and consolidated financial results for the quarter and year ended 31 March 2025, as required under SEBI Listing Regulations. Standalone total income from operations for FY25 stood at ₹2,53,394.5 lakhs, up about 18% from ₹2,14,142.9 lakhs in FY24, while standalone net profit after tax was ₹14,087.4 lakhs versus ₹33,512.4 lakhs in the previous year, the decline being largely on account of exceptional items related to the recently completed Heubach Group acquisition. Consolidated revenue for FY25 grew to ₹3,34,557.5 lakhs from ₹2,53,677.7 lakhs, but consolidated net profit after tax fell to ₹6,016.5 lakhs from ₹35,744.7 lakhs, again impacted by acquisition-related costs. The Board has recommended a dividend of 45 paise per share (22.5% on face value of ₹2) for FY25, subject to shareholder approval at the 74th AGM.
The sharp drop in net profit looks concerning on the surface but is largely explained by one-time costs linked to the Heubach acquisition completed on 3 March 2025 for around ₹1,36,890 lakhs, so underlying operating performance remains healthy with strong revenue growth. The dividend declaration and improving debt-equity ratio (standalone 0.18 vs 0.32) are positive signals for shareholders, while the Heubach deal is a key strategic event that could reshape future earnings.